
|Articles|July 1, 2001
Antibiotic therapy may pose risk for stone disease
Anaheim, CA- Epidemiologists, puzzling over metabolism, diet, food supplements, and genes, may have to look no further than the medicine chest to find one of the factors contributing to the putative rise in kidney stone disease. Three studies presented here at the annual AUA meeting suggest a link between calcium oxalate stones, the bacterium Oxalobacter formigenes, and antibiotics.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
NDV-01 produces robust 9-month results in high-risk NMIBC
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
SUO 2025 data confirm IsoPSA accuracy independent of mpMRI use
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5


















